Humana Inc. (NYSE:HUM) Shares Sold by AGF Management Ltd.

AGF Management Ltd. lowered its stake in Humana Inc. (NYSE:HUM - Free Report) by 14.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,478 shares of the insurance provider's stock after selling 1,431 shares during the quarter. AGF Management Ltd.'s holdings in Humana were worth $2,151,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Transcend Capital Advisors LLC lifted its holdings in Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after acquiring an additional 2,914 shares during the period. FNY Investment Advisers LLC lifted its holdings in Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after acquiring an additional 26,856 shares during the period. Retirement Systems of Alabama lifted its holdings in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock valued at $244,811,000 after acquiring an additional 65,735 shares during the period. Finally, PDT Partners LLC increased its position in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock valued at $1,286,000 after buying an additional 2,660 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Remove Ads

Humana Stock Down 1.0 %

NYSE HUM traded down $2.77 on Wednesday, reaching $267.01. The company had a trading volume of 1,506,592 shares, compared to its average volume of 1,714,284. The firm has a 50-day moving average of $271.45 and a 200-day moving average of $278.29. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The firm has a market capitalization of $32.23 billion, a PE ratio of 26.84, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is 35.58%.

Analysts Set New Price Targets

HUM has been the subject of a number of recent research reports. Piper Sandler lifted their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Truist Financial raised their price target on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research note on Monday, January 6th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price target on shares of Humana in a research note on Wednesday, February 12th. Morgan Stanley decreased their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Finally, Barclays raised their price target on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 13th. Nineteen analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $285.68.

Insider Buying and Selling at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.37% of the stock is currently owned by corporate insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.